Two major studies strengthen case for prostate cancer drug before chemotherapy
Pioneering prostate cancer drug abiraterone significantly extends the lives of…
5 February 2015 | By The Institute of Cancer Research
Pioneering prostate cancer drug abiraterone significantly extends the lives of men with advanced prostate cancer if given before chemotherapy, the results of a major phase III clinical trial have shown...